OraSure Technologies | OSUR - Ebitda



金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 217.7M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


Ebitda 更改 日
Agilent USD 540M 74M 2025-09
AngioDynamics USD 5.94M 3.78M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Illumina USD 469M 137M 2025-12
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 272.91M 24M 2026-03
STAAR Surgical USD -159K 34.78M 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Trinity Biotech USD -9.6M 7.64M 2024-12
Waters USD 380.97M 85.83M 2025-12